Our specialty hub programs are developed for complex patient journeys across a targeted range of disease states, including oncology, rare disease and cell & gene therapy (CGT). Each program is tailored to the needs of patients, providers and our partners, resulting in a focused hub model that reflects the realities of the patient journey.

We understand the importance of supporting patients and prescribers across the journey, whether by connecting patients with financial assistance, delivering consistent, compassionate case management, or helping providers navigate specialty prior authorization for the first time. We ground our program recommendations in a deep understanding of the specific provider base, allowing us to flex hub services up or down based on provider resources, experience and preferences. We also provide targeted support for specific patient populations, such as newborns, teenagers and geriatric patients, who may face unique barriers to access or adherence.